Clinical trial
Repeated Low-Level Red-Light Therapy for Shortening Axial Length in Chinese High Myopia Children and Teenagers: a Prospective Single-Arm Study
NCT05550740 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repeated Low-Level Red-Light Therapy for Shortening Axial Length in Chinese High Myopia Children and Teenagers: a Prospective Single-Arm Study
- Lead sponsor
- Shanghai Eye Disease Prevention and Treatment Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 19, 2022
- Completion date
- March 23, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
eye diseases, high myopia, refractive errors